A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 With Matrix-M in Combination With R21/Matrix-M | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 With Matrix-M in Combination With R21/Matrix-M	Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease	Active, not recruiting	Phase 2	2026-03-11		NCT07183371

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Bundesministerium für Forschung, Technologie und Raumfahrt (BMFTR)	3
European and Developing Countries Clinical Trials Partnership (EDCTP)	15
European Vaccine Initiative	6
Institut de Recherche en Sciences de la Sante, Burkina Faso	10
University of Oxford	213

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Institut de Recherche en Sciences de la Sante - Clinical Research Unit of Nanoro (IRSS-URCN)	Nanoro	Burkina Faso	1